A real-world observational retrospective cohort study of Canadian people living with HIV switching from nevirapine plus two nucleoside reverse transcriptase inhibitors to dolutegravir/lamivudine

被引：2
|
作者：
de Wet, Joseph J. [1 ,2 ]
Ban, Joann K. [3 ]
Verdier, Gustavo [4 ]
Ling, Juejing [5 ]
Eberg, Maria [5 ]
Bunko, Andrean [5 ]
McKimm, Michael [4 ,6 ]
机构：
[1] Spectrum Hlth, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada
[3] GSK, Mississauga, ON, Canada
[4] ViiV Healthcare, Montreal, PQ, Canada
[5] IQVIA, Kirkland, PQ, Canada
[6] ViiV Healthcare, 75 Queen St,Suite 1400, Montreal, PQ H3C2N6, Canada
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2023年 / 62卷 / 02期
关键词：
D O I：
10.1016/j.ijantimicag.2023.106839
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Comment on: Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study
    Bravo Urbieta, Joaquin
    Aleman Belando, Sergio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (11) : 2780 - 2782
  • [42] Performance of dolutegravir-based two-drug regimens (DTG-2DR) in a large real-world cohort of people with HIV
    Bowman, Conor
    Ambrose, Alissa
    Simoes, Pedro
    Florman, Katia
    Kanitkar, Tanmay
    Katiyar, Abhishek
    Hunter, Alan
    Hart, Jennifer
    Barber, Tristan
    HIV MEDICINE, 2022, 23 : 24 - 24
  • [43] Performance of dolutegravir-based two-drug regimens (DTG-2DR) in a large real-world cohort of people with HIV
    Bowman, C.
    Ambrose, A.
    Simoes, P.
    Florman, K.
    Kanitkar, T.
    Katiyar, A.
    Hunter, A.
    Hart, J.
    Barber, T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 94 - 95
  • [44] Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective study
    Matino, Davide
    Iorio, Alfonso
    Keepanasseril, Arun
    Germini, Federico
    Caillaud, Alexandre
    Carcao, Manuel
    Hews-Girard, Julia
    Iserman, Emma
    James, Paula
    Lee, Adrienne
    Phua, Chai W.
    Sun, Haowei
    Teitel, Jerome
    Man-Chiu Poon
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (03)
  • [45] Treatment patterns and preferences of people living with HIV starting or switching antiretroviral therapy: Real-world evidence from Portugal
    Pedro, Liliana
    Zagalo, Alexandra
    Tavares, Raquel
    Pacheco, Patricia
    Oliveira, Joaquim
    Vaz Pinto, Ines
    Serrao, Rosario
    Tavares, Sandra
    Brito, Paula
    Maltez, Fernando
    Neves, Isabel
    Carvalho, Alexandre
    Teofilo, Eugenio
    Almeida, Joana
    Lains, Ines
    INTERNATIONAL JOURNAL OF STD & AIDS, 2024, 35 (11) : 873 - 883
  • [46] Effectiveness of dolutegravir plus lamivudine in real-world studies in people with HIV-1 with M184V/I mutations: a systematic review and meta-analysis
    Kabra, M.
    Barber, T.
    Allavena, C.
    Marcelin, A.
    di Giambenedetto, S.
    Pasquau, J.
    Gianotti, N.
    Turner, M.
    Harrison, C.
    Wynne, T.
    Verdier, G.
    Parry, C.
    Jones, B.
    Okoli, C.
    Priest, J.
    Letang, E.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 79 - 81
  • [47] Effectiveness of dolutegravir plus lamivudine in real-world studies in people with HIV-1 with M184V/I mutations: a systematic review and meta-analysis
    Kabra, Madhusudan
    Barber, Tristan
    Allavena, Clotilde
    Marcelin, Anne-Genevieve
    Di Giambenedetto, Simona
    Pasquau, Juan
    Gianotti, Nicola
    Turner, Matthew
    Harrison, Cale
    Wynne, Tammy
    Verdier, Gustavo
    Parry, Chris
    Jones, Bryn
    Okoli, Chinyere
    Priest, Julie
    Letang, Emilio
    HIV MEDICINE, 2023, 24 : 29 - 30
  • [48] Non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance in people living with HIV-1 (PLWH) subtype non-B from the Swiss HIV Cohort Study (SHCS)
    Reichmuth, M. L.
    Kachalov, V.
    Boni, J.
    Perreau, M.
    Klimkait, T.
    Yerly, S.
    Hirsch, H. H.
    Hauser, C.
    Ramette, A.
    Vernazza, P.
    Cavassini, M.
    Bernasconi, E.
    Gunthard, H. F.
    Kouyos, R. D.
    HIV MEDICINE, 2019, 20 : 168 - 168
  • [49] Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar
    Benkhadra, Maria
    Elazzazy, Shereen
    Hamad, Anas Ahmad
    Elkhatim, Mohamed S.
    Gulied, Amaal
    Sahal, Arwa Osama
    Alasmar, Aya
    Jibril, Farah I.
    Afifi, Hebatalla Mahmoud
    Nasser, Sahar
    Alnajjar, Afnan
    Dawoud, Rawan
    Omar, Nabil E.
    BLOOD, 2023, 142
  • [50] Ritonavir-boosted darunavir plus two nucleoside reverse transcriptase inhibitors versus other regimens for initial antiretroviral therapy for people with HIV infection: a systematic review
    Balayan, T.
    Horvath, H.
    Rutherford, G. W.
    HIV MEDICINE, 2019, 20 : 234 - 234
12345